Analyst Ratings for Adamas Pharmaceuticals (ADMS) [Neutrals]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.7 / 10
Percentile Rank: 22%
Rating Score: 2.7 / 10
Percentile Rank: 22%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/17/2021 | Northland | Carl Byrnes | Downgrade | Market Perform (Outperform) |
8.50 (N/A) |
8.15 (8.22) |
0.86% | Details |
| 10/12/2021 | H.C. Wainwright | Raghuram Selvaraju | Downgrade | Neutral (Buy) |
N/A (N/A) |
8.07 (8.22) |
1.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
